Abbott, Medinol cardiac stent settlement enforced in court
This article was originally published in Clinica
Executive Summary
A settlement between Abbott Laboratories and Israeli stent specialist Medinol over the use of a licence for a patent held by the latter has been enforced by a US district court on August 7. The original settlement was reached in mid-2006, but questions had since been raised over how broadly Abbott could use the patents.